2016 WHO Classification update-What's new in lymphoid neoplasms.

about

Emerging antibody-drug conjugates for treating lymphoid malignancies.

P2860

Q38632313-ADBB5637-2F31-4B1D-B9CF-985E51EE4C53

P2860

2016 WHO Classification update-What's new in lymphoid neoplasms.

Item

http://www.wikidata.org/entity/Q39266295

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

2016 WHO Classification update-What's new in lymphoid neoplasms.

@en

2016 WHO Classification update-What's new in lymphoid neoplasms.

@nl

type

Item

label

2016 WHO Classification update-What's new in lymphoid neoplasms.

@en

2016 WHO Classification update-What's new in lymphoid neoplasms.

@nl

prefLabel

2016 WHO Classification update-What's new in lymphoid neoplasms.

@en

2016 WHO Classification update-What's new in lymphoid neoplasms.

@nl

P1476

2016 WHO Classification update-What's new in lymphoid neoplasms.

@en

P2093

E D Hsi

http://www.w3.org/2001/XMLSchema#string

P2860

BRAF mutations in hairy-cell leukemia

Characterization and treatment of chronic active Epstein-Barr virus disease: a 28-year experience in the United States

Molecular subtypes of diffuse large B-cell lymphoma arise by distinct genetic pathways

MYD88 L265P somatic mutation in Waldenström's macroglobulinemia.

Targeting Mutant BRAF in Relapsed or Refractory Hairy-Cell Leukemia

Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling

Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray

Exome sequencing identifies recurrent mutations of the splicing factor SF3B1 gene in chronic lymphocytic leukemia

A new immunostain algorithm classifies diffuse large B-cell lymphoma into molecular subtypes with high accuracy

Prognostic significance of MYC, BCL2, and BCL6 rearrangements in patients with diffuse large B-cell lymphoma treated with cyclophosphamide, doxorubicin, vincristine, and prednisone plus rituximab

P304

14-22

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/IJLH.12650

http://www.w3.org/2001/XMLSchema#string

P478

39 Suppl 1

http://www.w3.org/2001/XMLSchema#string

P577

2017-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28447410

http://www.w3.org/2001/XMLSchema#string

P921

Alþjóðaheilbrigðismálastofnunin

2016 WHO Classification update-What's new in lymphoid neoplasms.

about

P2860

P2860

2016 WHO Classification update-What's new in lymphoid neoplasms.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P698

P921